PT-141 + Selank for SSRI Users: Evidence Review

PT-141 (Bremelanotide) Evidence

PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo.

Human trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users.

Selank Evidence

Selank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal.

Additional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist.

Mechanisms (Mechanistic Tier)

PT-141 acts centrally via melanocortin receptors to modulate arousal signaling independent of vascular pathways.

Selank influences GABA-A receptor subunit expression and shows non-benzodiazepine anxiolytic activity in preclinical and limited human transcriptomic studies.

Combination and SSRI Context

No human data, preclinical studies, or user reports in indexed sources address the PT-141 + Selank combination or its use specifically for SSRI-induced sexual dysfunction and anxiety. Any application remains speculative.

Evidence Summary

PT-141: Human (FDA approval and phase 3 trials for HSDD).
Selank: Human (Russian clinical trials for GAD; limited Western validation).
SSRI-specific effects or stack: Speculative (no supporting data).

---

Related: Selank · PT-141

source_ledger· 3,302 words

Selank: one 62-patient trial against a benzodiazepine, and 40 people counted

Selank is a seven-amino-acid peptide developed in Moscow and approved in Russia in 2009 for generalised anxiety disorder. There is one controlled trial in people that carries almost the whole case: 62 patients, 30 given Selank and 32 given

converted from: markdown
original updated: 2026-08-04T21:15:55.616Z
register: source_ledger
category: null

source_ledger· 138 words

PT-141: Brain-Level Arousal

PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist that activates central nervous system pathways for sexual arousal signaling. humanmechanistic In two identical phase 3 randomized double-blind placebo-controlled trials

converted from: markdown
original updated: 2026-06-29T20:40:03.367Z
register: source_ledger
category: null

References (12)

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder“Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.”
VYLEESI Prescribing Information“VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).”
Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic and Dopaminergic Neurotransmission“Numerous clinical studies have shown that Selank has strong antianxiety and neuroprotective effects in the treatment of generalized anxiety disorders.”
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia“The effect of selank (30 patients) was compared to that of medazepam (32 patients).”
Bremelanotide: Uses, Interactions, Mechanism of Action“Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.”
Selank peptides, Can you take it with escitaloprám.“BUT I am on 5mg of escitalopram and Selank and my Dr said it was fine. So, while my case is similar, its not exactly the same but similar.”
Anyone taking Semax and Selank. What is your experience“I love the S&S blend off crafters. It’s pretty good as I have anxiety And take Zoloft. It works with my current prescription.”
Full PT-141 Guide“This is why people use it for: • Low libido • Performance anxiety • SSRI sexual sides • “Everything works but I don’t feel it””
PT-141 - Peptide Affect“PT-141 + Selank – Calm and Desire Balance **Summary:** A calming, balanced stack for those who experience anxiety or performance-related inhibition. **Why it works:** Selank reduces anxiety by supporting GABA signaling in the brain. This can help relax the nervous system and remove emotional blocks to desire. PT-141 + SSRIs or Dopaminergic Medications – Unpredictable Mood Interactions **Summary:*”
Peptides With Psychiatric Medications: A Psychiatrists Guide“Selank is the more cautious case. The peptide slows enzymatic breakdown of serotonin in certain brain regions, which increases serotonin availability through a different mechanism than an SSRI’s reuptake blockade, but in the same direction. The combination is not equivalent to stacking two direct serotonergic drugs, and it is not the same as combining an SSRI with an MAOI (the classic high-risk pa”
Has anyone tried PT-141, selank, or semax?“Has anyone tried PT-141 , selank , or semax? These are kind of the brain stimulating peptides that are supposed to be fast acting. I was ...”
Love Potion (PT141-Selank-Oxytocin) nasal spray“Minus oxytocin (personally, subq was a nightmare), selank and PT-141 seem better to me at least, subcutaneous. First time, 0.6 mg PT-141 .”

The system

Messaging

Ads and leads

Devices

Industries